NCT00301964
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Uterine Neoplasms
Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.
2,258 public trials
566 recruiting studies
Uterine Neoplasms trial results
NCT00025233
- Conditions
- Cervical Squamous Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00095979
- Conditions
- Endometrial Adenocarcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00096447
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00462826
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- Washington Hospital Center Washington D.C., District of Columbia, United States
- Jupiter Medical Center Jupiter, Florida, United States
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, +25 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of California at Los Angeles Health System Los Angeles, California, United States
- Olive View-University of California Los Angeles Medical Center Sylmar, California, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
Completed
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
NCT00723255
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- Washington Hospital Center Washington D.C., District of Columbia, United States
- Memorial University Medical Center Savannah, Georgia, United States
NCT00729586
- Conditions
- Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +17 more
- Locations
-
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of California San Diego San Diego, California, United States
- Colorado Gynecologic Oncology Group Aurora, Colorado, United States
NCT00803062
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
NCT03420157
- Conditions
- Behavior, Cancer Cervix, Communication, +13 more
- Locations
-
- UH Tours Tours, Indre-et-Loire, France